716-1447

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2013-12-16

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild CHEST PAIN — outcome: RECOVERED/RESOLVED; onset 2014-04-05 (study day 111.0); relationship: REMOTE

mild assessed

Mild ELECTROCARDIOGRAM T WAVE INVERSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-14 (study day 89.0); relationship: POSSIBLE

moderate assessed

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 30.0); relationship: PROBABLE

mild assessed

Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-01 (study day 17.0); relationship: POSSIBLE

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 30.0); relationship: PROBABLE

Data queries

No data queries.